Robert W. Baird Increases AdaptHealth (NASDAQ:AHCO) Price Target to $16.00

AdaptHealth (NASDAQ:AHCO) had its price objective lifted by equities researchers at Robert W. Baird from $14.00 to $16.00 in a research note issued on Thursday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Robert W. Baird’s target price would indicate a potential upside of 40.60% from the stock’s current price.

A number of other analysts have also recently commented on the company. Canaccord Genuity Group lifted their price target on AdaptHealth from $13.00 to $14.00 and gave the stock a “buy” rating in a research report on Wednesday. Royal Bank of Canada boosted their price objective on AdaptHealth from $11.00 to $14.00 and gave the company an “outperform” rating in a report on Wednesday. UBS Group decreased their price objective on AdaptHealth from $12.00 to $11.00 and set a “buy” rating for the company in a report on Thursday, February 13th. Finally, Truist Financial boosted their price objective on AdaptHealth from $12.00 to $14.00 and gave the company a “buy” rating in a report on Wednesday. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, AdaptHealth has a consensus rating of “Buy” and an average target price of $13.80.

AdaptHealth Stock Performance

Shares of AHCO opened at $11.38 on Thursday. The stock has a 50-day moving average of $9.92 and a two-hundred day moving average of $10.23. AdaptHealth has a one year low of $8.35 and a one year high of $11.90. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. The stock has a market cap of $1.53 billion, a P/E ratio of -6.90, a P/E/G ratio of 1.08 and a beta of 1.12.

Hedge Funds Weigh In On AdaptHealth

Institutional investors and hedge funds have recently modified their holdings of the business. Assetmark Inc. purchased a new position in shares of AdaptHealth in the 4th quarter valued at about $28,000. Blue Trust Inc. increased its stake in shares of AdaptHealth by 24.1% in the 4th quarter. Blue Trust Inc. now owns 5,746 shares of the company’s stock valued at $55,000 after purchasing an additional 1,115 shares in the last quarter. Quarry LP increased its stake in shares of AdaptHealth by 4,596.9% in the 3rd quarter. Quarry LP now owns 5,965 shares of the company’s stock valued at $67,000 after purchasing an additional 5,838 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its stake in shares of AdaptHealth by 15.4% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company’s stock valued at $121,000 after purchasing an additional 1,690 shares in the last quarter. Finally, CIBC Asset Management Inc purchased a new position in shares of AdaptHealth in the 3rd quarter valued at about $122,000. Hedge funds and other institutional investors own 82.67% of the company’s stock.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.